GNH USA

Europe — EMA

Minisiston 20 Fem (Ethinylestradiol, Levonorgestrel)

GNH USA supplies Minisiston 20 Fem (Ethinylestradiol / Levonorgestrel), a combined oral contraceptive for prevention of pregnancy. Request a quote for supply.

Ethinylestradiol, Levonorgestrel

Request sourcing

1
Pack/s

What is Ethinylestradiol, Levonorgestrel?

Ethinylestradiol and Levonorgestrel, the active ingredients in Minisiston 20 Fem, are a combined oral contraceptive presented as Ethinylestradiol 20 µg / Levonorgestrel 100 µg tablets for oral use. It is prescribed to prevent pregnancy in women of reproductive age. GNH USA supplies Minisiston 20 Fem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ethinylestradiol, Levonorgestrel used for?

Minisiston 20 Fem, a combined oral contraceptive, works within the hormonal reproductive pathway to prevent unintended pregnancy. - Prevention of pregnancy: Provides reliable contraceptive protection when taken as directed. - Regulation of menstrual cycles: Helps achieve more predictable cycle timing and flow. - Treatment of moderate acne: Reduces androgen‑driven skin lesions in some women.

What are the side effects of Ethinylestradiol, Levonorgestrel?

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Headache: Tension‑type or migraine‑like pain. - Breast tenderness: Temporary swelling or discomfort. - Spotting between periods: Light bleeding episodes. - Weight fluctuations: Minor changes in fluid retention. - Mood changes: Irritability or mild mood swings.

Serious or Rare Side Effects: - Deep vein thrombosis: Blood clot formation in legs. - Pulmonary embolism: Blockage of lung arteries. - Stroke: Cerebrovascular accident risk. - Severe allergic reaction: Rash, swelling, or breathing difficulty. - Liver dysfunction: Jaundice or abnormal liver enzymes. - Hypertension: Significant rise in blood pressure.

What precautions apply to Ethinylestradiol, Levonorgestrel?

Before using Minisiston 20 Fem, consider the following precautions: - Smoking: Avoid if over 35 years old and a smoker due to increased cardiovascular risk. - History of clotting disorders: Discuss with a healthcare professional. - Migraine with aura: Use alternative contraception if present. - Liver disease: Assess liver function prior to initiation. - Breast cancer history: Contraindicated in active or past cases. - Store at ambient temperature: Keep below 25°C, retain in original packaging, protect from moisture.

What does Ethinylestradiol, Levonorgestrel interact with?

Minisiston 20 Fem may interact with several medicines. Major Interactions (Avoid): - Antiepileptic enzymes inducers (e.g., carbamazepine, phenytoin): Reduce contraceptive efficacy. - Rifampin and other potent inducers: May lead to contraceptive failure. - Certain HIV protease inhibitors: Can increase hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): May increase hormone concentrations. - St. John’s Wort: May lower effectiveness of the pill. - Antibiotics (e.g., tetracycline): Generally minimal effect but monitor for breakthrough bleeding.

Frequently asked questions

What is Minisiston 20 Fem used for?+
Minisiston 20 Fem is a combined oral contraceptive tablet containing ethinylestradiol and levonorgestrel. It is prescribed to prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the uterine lining to reduce the chance of implantation.
How does ethinylestradiol work in this product?+
Ethinylestradiol is a synthetic estrogen that suppresses the release of follicle‑stimulating hormone from the pituitary gland. This suppression helps prevent the development of a dominant follicle, thereby reducing the likelihood of ovulation when used with levonorgestrel.
What is the usual dose of Minisiston 20 Fem?+
The dosing regimen for Minisiston 20 Fem is determined by the prescribing clinician. Typically, the tablet is taken once daily at the same time each day, but the exact schedule should follow the healthcare provider’s instructions.
Is Minisiston 20 Fem safe to use during pregnancy or breastfeeding?+
Minisiston 20 Fem is not intended for use during pregnancy and should be discontinued if pregnancy occurs. Limited data are available for breastfeeding; women should discuss risks and benefits with their healthcare professional before using the product while nursing.
How do I order Minisiston 20 Fem from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Minisiston 20 Fem compare with other combined oral contraceptives?+
Minisiston 20 Fem contains a low‑dose estrogen (20 µg) combined with 100 µg levonorgestrel, offering effective contraception with a favorable side‑effect profile. Compared with higher‑dose formulations, it may reduce estrogen‑related adverse events while maintaining comparable contraceptive efficacy.
What are the storage requirements for Minisiston 20 Fem?+
Store Minisiston 20 Fem at ambient temperature below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.
How is Minisiston 20 Fem administered?+
The tablet is taken orally, usually with water, once each day at the same time. It should be swallowed whole and not chewed or broken. Consistency in timing helps maintain steady hormone levels for optimal contraceptive effect.
What are the most serious risks associated with Minisiston 20 Fem?+
Serious risks include venous thromboembolism, pulmonary embolism, stroke, and myocardial infarction, especially in women who smoke, are over 35 years old, or have a history of clotting disorders. Prompt medical attention is required if symptoms such as severe leg pain, chest pain, or sudden neurological changes occur.
Who should not use Minisiston 20 Fem?+
Women with a known hypersensitivity to either component, active or past breast cancer, uncontrolled hypertension, a history of thromboembolic disease, or those who are pregnant should avoid using Minisiston 20 Fem. Consultation with a healthcare professional is essential to assess suitability.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ethinylestradiol, Levonorgestrel
Route
Oral Use
Manufacturer
Jenapharm Gmbh & Co Kg
Origin
EU

Related products

Adepal

Adepal

Ethinylestradiol, Levonorgestrel

Pfizer Holding France
EU
Adexa

Adexa

Ethinylestradiol, Levonorgestrel

Mibe Pharmaceuticals D.O.O.
EU
Aileva

Aileva

Ethinylestradiol, Levonorgestrel

Laboratorios Cinfa S.A.
EU
Ambelina

Ambelina

Ethinylestradiol, Levonorgestrel

Crescent Pharma Limited
EU